Cardiovascular therapeutics a companion to Braunwald's heart disease
This companion to Braunwald's Heart Disease equips you with all of today's most effective therapeutic guidelines and management solutions for the full range of heart disease patients. It reflects the most recent standards for drug management as well as the latest in new technologies. Reorg...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Philadelphia, PA
Elsevier/Saunders
2013
|
| Edition: | 4th ed. |
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- PART I DECISION MAKING AND THERAPEUTIC STRATEGIES IN CARDIOVASCULAR MEDICINE
- Chapter 1 Tools for Assessment of Cardiovascular Tests and Therapies
- Chapter 2 New Drug Development
- Chapter 3 Device Development for Cardiovascular Therapeutics: Concepts and Regulatory Implications
- Chapter 4 Pharmacogenetics Chapter
- 5 Systems of Health Care
- Chapter 6 Global Cardiovascular Therapy
- PART II ISCHEMIC HEART DISEASE
- Chapter 7 Pharmacologic Options for Treatment of Ischemic Disease
- Chapter 8 Stable Ischemic Heart Disease/Chronic Stable Angina
- Chapter 9 Non-ST-Segment Elevation Acute Coronary Syndromes
- Chapter 10 ST-Segment Elevation Myocardial Infarction
- Chapter 11 Advances in Coronary Revascularization
- PART III HEART FAILURE
- Chapter 12 Pharmacologic Management of Heart Failure in the Ambulatory Setting
- Chapter 13 Implantable Devices for the Management of Heart Failure
- Chapter 14 Strategies for Management of Acute Decompensated Heart Failure
- Chapter 15 Cardiac Transplantation and Circulatory Support Devices Chapter
- 16 Regenerative Therapy for Heart Failure Chapter
- 17 Hypertrophic, Restrictive, and Infiltrative Cardiomyopathies
- PART IV ARRHYTHMIAS AND CONDUCTION DISTURBANCES
- Chapter 18 Clinical Pharmacology of Antiarrhythmic Drugs
- Chapter 19 Pharmacologic Management of Supraventricular Tachycardias
- Chapter 20 Atrial Fibrillation
- Chapter 21 Nonpharmacologic Treatment of Tachyarrhythmias
- Chapter 22 Role of Implantable Cardioverter-Defibrillators in Primary and Secondary Prevention of Sudden Cardiac Death
- Chapter 23 Treatment of Ventricular Tachycardia and Cardiac Arrest
- PART V DYSLIPOPROTEINEMIAS AND ATHEROSCLEROSIS
- Chapter 24 Drugs for Elevated Low-Density Lipoprotein Cholesterol
- Chapter 25 Therapy to Manage Low High-Density Lipoprotein Cholesterol and Elevated Triglycerides
- Chapter 26 Cardiovascular Disease and Lifestyle Modification
- Chapter 27 Steps Beyond Diet and Drug Therapy for Severe Hypercholesterolemia PART VI HYPERTENSION
- Chapter 28 Initial Evaluation and Approach to the Patient with Hypertension
- Chapter 29 Pharmacologic Management of Hypertension
- Chapter 30 Endocrine Causes of Hypertension
- Chapter 31 Resistant Hypertension
- Chapter 32 Hypertensive Crisis
- Chapter 33 Hypertension in Pregnancy
- Chapter 34 Management of Hypertension in Children and Adolescents PART VII OTHER VASCULAR CONDITIONS
- Chapter 35 Peripheral Artery Disease Chapter 36 Cerebrovascular Disease
- Chapter 37 Renal Artery Stenosis
- Chapter 38 Pulmonary Embolism and Deep Vein Thrombosis
- Chapter 39 Treatment of Pulmonary Arterial Hypertension
- Chapter 40 Aortic Disease
- PART VIII OTHER CARDIOVASCULAR CONDITIONS
- Chapter 41 Pharmacologic Options for Treating of CardiovascularDisease During Pregnancy
- Chapter 42 Care for Adults with Congenital Heart Disease
- Chapter 43 Prevention and Treatment of Infective Endocarditis
- Chapter 44 Treatment of Pericardial Disease
- Chapter 45 Optimal Timing of Surgical and Mechanical Intervention in Native Valvular Heart Disease
- Chapter 46 Surgery for Valvular Heart Disease
- Chapter 47 Percutaneous Treatment for Valvular Heart Disease
- Chapter 48 Manifestations, Mechanisms, and Treatment of HIV-Associated Cardiovascular Disease
- Chapter 49 Rehabilitation of the Patient with Cardiovascular Disease
- PART IX APPENDIX Cardiovascular Devices